KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress.
about
ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease.Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases.KUS121, an ATP regulator, mitigates chorioretinal pathologies in animal models of age-related macular degeneration.Branched chain amino acids attenuate major pathologies in mouse models of retinal degeneration and glaucoma.
P2860
KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
KUS121, a VCP modulator, atten ...... endoplasmic reticulum stress.
@en
KUS121, a VCP modulator, atten ...... endoplasmic reticulum stress.
@nl
type
label
KUS121, a VCP modulator, atten ...... endoplasmic reticulum stress.
@en
KUS121, a VCP modulator, atten ...... endoplasmic reticulum stress.
@nl
prefLabel
KUS121, a VCP modulator, atten ...... endoplasmic reticulum stress.
@en
KUS121, a VCP modulator, atten ...... endoplasmic reticulum stress.
@nl
P2093
P2860
P356
P1433
P1476
KUS121, a VCP modulator, atten ...... endoplasmic reticulum stress.
@en
P2093
Akira Kakizuka
Chinami Kikkawa
Hanako O Ikeda
Masayuki Hata
Tomoko Hasegawa
Yuki Muraoka
P2860
P2888
P356
10.1038/SREP44873
P407
P577
2017-03-20T00:00:00Z